Agenda
25 CE/CME Credits (7 In-Person and 18 Online)
After completing this activity, participants will be able to:
- Identify the evidence for emerging pharmaceutical and device-based therapies for common pediatric and adult skin conditions
- Incorporate the use of biologics and JAK inhibitors into an integrative treatment plan for inflammatory skin conditions
- Examine the clinical evidence for influence of epigenetic markers on aging and skin inflammation
- Diagram the role of the gut and skin microbiome in inflammation and the skin barrier
- Discuss the clinical evidence for the use of non-steroidal topicals to control skin inflammation
- Compare treatment approaches based on skin type and color
.
Speaker: Vivian Shi, MD
Speaker: Sarina Elmariah, MD
Moderator: Peter Lio, MD
Panelists: Sarina Elmariah, MD
Speaker: Neal Bhatia, MD
Description: This lecture provides a practical overview of hormonal replacement therapy (HRT), focusing on its role in managing hormonal imbalances and associated dermatologic conditions. Participants will gain insights into patient evaluation, hormone selection, and monitoring strategies to optimize safety and efficacy. Evidence-based approaches and case studies will be highlighted to guide practitioners in implementing HRT in clinical practice.
Learning Objective:
- Identify indications for hormonal replacement therapy and its relevance to dermatologic conditions.
- Evaluate patient profiles to determine appropriate candidates for HRT.
- Discuss the benefits, risks, and monitoring strategies associated with HRT.
- Develop personalized treatment plans incorporating HRT to manage hormonal imbalances effectively.
Speaker: Joseph Alban, DAc
Speaker: Nada Elbuluk, MD MSc
Speaker: Seemal Desai, MD
Speaker: Zoe Draelos, MD
Speaker: Steven Daveluy, MD
Speaker: Hadar Lev-Tov, MD
Speaker: Jennifer Soung, MD